textjournal article
Assessment of CRB1-associated retinopathies using the S-MAIA fast protocol and spectral-domain optical coherence tomography.
Abstract
Background: A cross-sectional study was conducted at Moorfields Eye Hospital, UK, involving patients with CRB1-associated retinopathies: macular dystrophy (MD), cone-rod dystrophy (CORD), and early-onset severe retinal dystrophy/Leber congenital amaurosis (EOSRD/LCA). The study aimed to evaluate CRB1-associated retinopathies using microperimetry (macular integrity assessment (S-MAIA) fast protocol) and spectral domain optical coherence tomography (SD-OCT). Methods: Data quality and participant attrition were assessed in 18 patients (10 MD, 5 EOSRD/LCA, 3 CORD), aged 10-52 years, with a median best corrected visual acuity (BCVA) of 0.41 logMAR. Results: Microperimetry and SD-OCT data were obtained from 14 and 18 patients, respectively, but eccentric fixation hindered structure-function analysis. All participants showed overall abnormal sensitivity on the S-MAIA fast protocol. Parafoveal volume was significantly increased, while foveal thickness and volume were reduced compared to normative data (p < 0.01). Conclusions: This study highlights the challenges of participant attrition and the need for alternative functional metrics to complement traditional evaluations. It also reinforces previous findings of abnormal retinal architecture in CRB1-associated retinopathies, providing further insights into S-MAIA and SD-OCT assessments for this patient population- Text
- Journal contribution
- Neurosciences
- Model organisms
- Gene Expression
- Genetics & Genomics
- Developmental Biology
- Human Biology & Physiology
- Stem Cells
- cone-rod dystrophy (CORD)
- crumbs cell polarity complex component 1 gene (CRB1)
- early-onset severe retinal dystrophy (EOSRD)
- Leber congenital amaurosis (LCA)
- macular dystrophy (MD)
- macular integrity assessment (S-MAIA)
- spectral domain optical coherence tomography (SD-OCT)
- Moosajee - sec
- 3101 Biochemistry and cell biology
- 3214 Pharmacology and pharmaceutical sciences
- 3404 Medicinal and biomolecular chemistry